108 related articles for article (PubMed ID: 3111137)
1. Systemic effects of 1,25-dihydroxyvitamin D3 on the pituitary-hypothalamic axis in rats.
Törnquist K; Lamberg-Allardt C
Acta Endocrinol (Copenh); 1987 Jun; 115(2):225-8. PubMed ID: 3111137
[TBL] [Abstract][Full Text] [Related]
2. Effects of tri-iodothyronine, cortisol and transcriptional inhibitors on vitamin D3-enhanced thyrotrophin secretion by rat pituitary cells in vitro.
d'Emden MC; Wark JD
J Endocrinol; 1989 Jun; 121(3):451-8. PubMed ID: 2502597
[TBL] [Abstract][Full Text] [Related]
3. 1,25-Dihydroxyvitamin D3 enhances thyrotropin releasing hormone induced thyrotropin secretion in normal pituitary cells.
D'Emden MC; Wark JD
Endocrinology; 1987 Sep; 121(3):1192-4. PubMed ID: 3113918
[TBL] [Abstract][Full Text] [Related]
4. Effect of 1,25-dihydroxyvitamin D3 on rat pituitary prolactin release.
Törnquist K
Acta Endocrinol (Copenh); 1987 Dec; 116(4):459-64. PubMed ID: 3425161
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D-enhanced thyrotrophin release from rat pituitary cells: effects of Ca2+, dihydropyridines and ionomycin.
d'Emden MC; Wark JD
J Endocrinol; 1989 Jun; 121(3):441-50. PubMed ID: 2474048
[TBL] [Abstract][Full Text] [Related]
6. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone.
Duntas L; Roussel JP; Astier H; Keck FS; Rosenthal J; Pfeiffer EF
Pharmacology; 1991; 43(2):106-12. PubMed ID: 1775509
[TBL] [Abstract][Full Text] [Related]
7. Direct in vitro effect of thyroid hormones on 25-hydroxyvitamin D3 metabolism in the perfused rat kidney.
Kano K; Jones G
Endocrinology; 1984 Feb; 114(2):330-6. PubMed ID: 6418528
[TBL] [Abstract][Full Text] [Related]
8. Effects of vitamin D3 metabolites on thyrotropin secretion from rat pituitary cells in culture.
Törnquist K; Forss L; Lamberg-Allardt C
J Endocrinol Invest; 1990 May; 13(5):391-5. PubMed ID: 2380504
[TBL] [Abstract][Full Text] [Related]
9. Culture requirements for optimal expression of 1 alpha,25-dihydroxyvitamin D3-enhanced thyrotropin secretion.
d'Emden MC; Wark JD
In Vitro Cell Dev Biol; 1991 Mar; 27A(3 Pt 1):197-204. PubMed ID: 1903381
[TBL] [Abstract][Full Text] [Related]
10. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
Mortensen BM; Gautvik KM; Gordeladze JO
Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1,25-dihydroxyvitamin D3 on TSH secretion from rat pituitary cells in culture.
Törnquist K; Lamberg-Allardt C
Acta Endocrinol (Copenh); 1987 Mar; 114(3):357-61. PubMed ID: 3564838
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3-induced upregulation of the thyrotropin-releasing hormone receptor in clonal rat pituitary GH3 cells.
Atley LM; Lefroy N; Wark JD
J Endocrinol; 1995 Dec; 147(3):397-404. PubMed ID: 8543909
[TBL] [Abstract][Full Text] [Related]
13. Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis.
van Haasteren GA; van der Meer MJ; Hermus AR; Linkels E; Klootwijk W; Kaptein E; van Toor H; Sweep CG; Visser TJ; de Greef WJ
Endocrinology; 1994 Oct; 135(4):1336-45. PubMed ID: 7925094
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic treatment with thyrotropin-releasing hormone (TRH) or an analog of TRH (linear beta-alanine TRH) on the hypothalamic-pituitary-thyroid axis.
Nemeroff CB; Bissette G; Martin JB; Brazeau P; Vale W; Kizer JS; Prange AJ
Neuroendocrinology; 1980 Apr; 30(4):193-9. PubMed ID: 6769064
[TBL] [Abstract][Full Text] [Related]
15. Possible role of corticosterone in the down-regulation of the hypothalamo-hypophysial-thyroid axis in streptozotocin-induced diabetes mellitus in rats.
van Haasteren GA; Sleddens-Linkels E; van Toor H; Klootwijk W; de Jong FH; Visser TJ; de Greef WJ
J Endocrinol; 1997 May; 153(2):259-67. PubMed ID: 9166115
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 attenuates adenylyl cyclase activity in rat thyroid cells: reduction of thyrotropin receptor number and increase in guanine nucleotide-binding protein Gi-2 alpha.
Berg JP; Sandvik JA; Ree AH; Sørnes G; Bjøro T; Torjesen PA; Gordeladze JO; Haug E
Endocrinology; 1994 Aug; 135(2):595-602. PubMed ID: 8033808
[TBL] [Abstract][Full Text] [Related]
17. Effects of neonatal hyperthyroidism on the development of the hypothalamic-pituitary-thyroid axis in the rat.
Dussault JH; Coulombe P; Walker P
Endocrinology; 1982 Mar; 110(3):1037-42. PubMed ID: 6799277
[TBL] [Abstract][Full Text] [Related]
18. Sequential changes in the pituitary thyroid axis after chronic TRH administration: effects on euthyroid and thyroxine treated female rats.
Iglesias R; Llobera M; Montoya E
Acta Endocrinol (Copenh); 1985 Jun; 109(2):237-42. PubMed ID: 3925674
[TBL] [Abstract][Full Text] [Related]
19. Effect of diphenylhydantoin on hypothalamic-pituitary-thyroid function in the rat.
Theodoropoulos T; Fang SL; Azizi F; Ingbar SH; Vagenakis AG; Braverman LE
Am J Physiol; 1980 Dec; 239(6):E468-73. PubMed ID: 6778221
[TBL] [Abstract][Full Text] [Related]
20. Effects of food deprivation on the feedback regulation of the hypothalamic-pituitary-thyroid axis of the rat.
Connors JM; DeVito WJ; Hedge GA
Endocrinology; 1985 Sep; 117(3):900-6. PubMed ID: 3926471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
